AstraZeneca Sues Aurobindo For Nexium Patent Infringement

By Bill Wichert ( July 21, 2016, 7:24 PM EDT) -- AstraZeneca AB slammed Aurobindo Pharma Ltd. with a patent infringement lawsuit in New Jersey federal court on Wednesday over the generics maker's versions of Nexium, claiming the company should be barred from selling the drugs before AstraZeneca's patents and any additional periods of exclusivity expire....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!